Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Invesco Biotechnology & Genome ETF (NY:PBE)

81.11 UNCHANGED
Streaming Delayed Price Updated: 8:00 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 81.11
Bid (Size) 76.37 (100)
Ask (Size) 85.60 (100)
Prev. Close 81.11
Today's Range 81.11 - 81.11
52wk Range 54.52 - 83.59
Shares Outstanding 34,500
Dividend Yield 0.58%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
MannKind Stock Soared 8% Today: Why A Surge In Afrezza Inhaled Insulin Sales Matters ↗
Via Stocktwits
Akebia Therapeutics Stock Slumps After FDA Meeting Ends Without Path Forward for Vafseo Label Expansion ↗
Via Stocktwits

Performance

YTD
+20.9%
+20.9%
1 Month
+4.6%
+4.6%
3 Month
+16.5%
+16.5%
6 Month
+25.7%
+25.7%
1 Year
+17.9%
+17.9%

More News

Read More
News headline image
Pharma ETFs In A Tariff Storm: How Investors Can Hedge Risk ↗
Via Benzinga
Topics ETFs
Ionis Pharma Stock Rises After Multiple Price Target Hikes On Heels Of Positive Study Results In Alexander Disease ↗
Via Stocktwits
News headline image
3 Biotech Stocks to Buy That Have CRISPR-Like Breakthrough Potential ↗
Via InvestorPlace
News headline image
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
Via Benzinga
News headline image
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
Via Benzinga
News headline image
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
Via Benzinga
News headline image
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
Via Benzinga
News headline image
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗
Via Benzinga
News headline image
US Judge Weighs Nationwide Ban On Abortion Pills ↗
Via Benzinga
News headline image
FDA Takes Action To Restrict Unlawful Import Of Animal Tranquilizer 'Tranq' Or ''Zombie Drug' ↗
Via Benzinga
News headline image
7 Best Biotech Stocks to Buy in July 2022 ↗
Via InvestorPlace
News headline image
Biotech ETFs That Outperformed Last Week ↗
Via Talk Markets
News headline image
A Comprehensive Guide To Genomic ETFs ↗
Via Talk Markets
News headline image
5 Top ETFs With Exposure To Biogen ↗
Via Talk Markets
News headline image
5 Top ETFs With Exposure To Biogen ↗
Via Benzinga
News headline image
3 Biotech Stocks Wall Street Predicts Will Rally By 45% Or More ↗
Via Talk Markets

Frequently Asked Questions

Is Invesco Biotechnology & Genome ETF publicly traded?
Yes, Invesco Biotechnology & Genome ETF is publicly traded.
What exchange does Invesco Biotechnology & Genome ETF trade on?
Invesco Biotechnology & Genome ETF trades on the New York Stock Exchange
What is the ticker symbol for Invesco Biotechnology & Genome ETF?
The ticker symbol for Invesco Biotechnology & Genome ETF is PBE on the New York Stock Exchange
What is the current price of Invesco Biotechnology & Genome ETF?
The current price of Invesco Biotechnology & Genome ETF is 81.11
When was Invesco Biotechnology & Genome ETF last traded?
The last trade of Invesco Biotechnology & Genome ETF was at 12/15/25 08:00 PM ET
What is the market capitalization of Invesco Biotechnology & Genome ETF?
The market capitalization of Invesco Biotechnology & Genome ETF is 2.80M
How many shares of Invesco Biotechnology & Genome ETF are outstanding?
Invesco Biotechnology & Genome ETF has 3M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.